SCHEMBL5465100

SCHEMBL5465100

Cc1nc(N)nc2c1C(=O)CC(c1ccccc1-c1cccc(C(N)=O)c1)C2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 9/20 0.55
HSP90AB1 P08238 7/20 0.55
BRD4 O60885 1/20 0.40
CREBBP Q92793 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ADRA2A P08913 1/20 0.38
ADRA1A P35348 1/20 0.38
TRAP1 Q12931 1/20 0.38
TSHR P16473 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PDE2A O00408 1/20 0.36
PDE5A O76074 1/20 0.36
PDE7A Q13946 1/20 0.36
PDE11A Q9HCR9 1/20 0.36
PDE10A Q9Y233 1/20 0.36
BAZ2B Q9UIF8 1/20 0.36
BAZ2A Q9UIF9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5457927 0.90 HSP90AA1 (0.53) HSP90AA1HSP90AB1NPC1RAB9AADRA2A
SCHEMBL14582311 0.88 HSP90AA1 (0.60) HSP90AA1HSP90AB1RAB9ATRAP1TSHR
SCHEMBL14582312 0.87 HSP90AA1 (0.58) HSP90AA1HSP90AB1TRAP1TSHRALDH1A1
SCHEMBL1780605 0.86 HSP90AA1 (0.70) HSP90AA1HSP90AB1BRD4TRAP1TSHR
SCHEMBL14582445 0.84 HSP90AA1 (0.55) HSP90AA1HSP90AB1BRD4TRAP1TSHR
SCHEMBL14582323 0.84 HSP90AA1 (0.55) HSP90AA1HSP90AB1TRAP1TSHRALDH1A1
SCHEMBL5466848 0.84 HSP90AA1 (0.55) HSP90AA1HSP90AB1BRD4CREBBPTRAP1
SCHEMBL14582357 0.84 HSP90AA1 (0.55) HSP90AA1HSP90AB1BRD4TRAP1ALDH1A1
SCHEMBL5472446 0.84 HSP90AA1 (0.53) HSP90AA1HSP90AB1BRD4CREBBPNPC1
SCHEMBL5471679 0.83 HSP90AA1 (0.54) HSP90AA1HSP90AB1CREBBPTRAP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027150-A1 2-Amino-quinazolin-5-ones TK1, TK2, SLC1A5 HSP90AA1 3373/4885HSP90AB1 3036/4885BRD4 1642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.